Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma

Clinical trial NCT06199297 · COMPLETED

Trial details

NCT number: NCT06199297
Sponsor: Sun Yat-sen University
Status: COMPLETED
Study type: OBSERVATIONAL

Hepatocellular Carcinoma

Start date: 2021-03-02
Primary completion: 2023-07-25
Enrollment: 188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.